COMMUNIQUÉS West-GlobeNewswire

Solon Eiendom ASA – Primary insider notification
19/09/2018
(Oslo, Norway, September 18, 2018) Solon Eiendom ASA Board Member Tore Aksel Voldberg has today through his wholly owned company Skøien AS bought 20.000 shares in Solon Eiendom ASA at a price of NOK 29.017. Following [...]
Polydex Reports Second Quarter Financial Results
19/09/2018
Sales Remain Consistent, Profits Up TORONTO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC/Pink:POLXF) (the “Company”) today announced financial results for the second quarter of the 2019 [...]
SPINEWAY : Souscription de 100 OCEANE
19/09/2018
Souscription de 100 obligations convertibles ou échangeables en actions nouvelles et/ou existantes (OCEANE) assorties de bons de souscription d'actions pour un montant nominal d'1 MEUR Spineway (la « Société ») annonce [...]
Rule 2.9 Announcement
19/09/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 19 September 2018 [...]
PCI Biotech: Commencement of subscription period
19/09/2018
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, HONG KONG OR SOUTH AFRICA, OR ANY OTHER [...]
Bavarian Nordic Delivers Smallpox Vaccine to England in Response to Current Monkeypox Cases
19/09/2018
English health authorities have ordered IMVANEX smallpox vaccine in response to monkeypox cases Immediate response ensured rapid delivery and deployment of vaccines COPENHAGEN, Denmark, September 19, 2018 - After the [...]
G1 Therapeutics Announces Pricing of Offering of Common Stock
19/09/2018
RESEARCH TRIANGLE PARK, N.C., Sept. 18, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced the pricing of an underwritten public offering of 3,000,000 [...]
argenx raises approximately $300.6 million in gross proceeds in a U.S. public offering
19/09/2018
Regulated information - Inside information September 18, 2018, 8:45 PM ET - September 19, 2018, 2:45 AM CEST Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX) a clinical-stage biotechnology [...]
MediciNova to Present at the Ladenburg Thalmann 2018 Healthcare Conference in New York
19/09/2018
LA JOLLA, Calif., Sept. 18, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), [...]
Positive PEACHTREE Data to be Highlighted at EURETINA 2018
18/09/2018
ALPHARETTA, Ga., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]
3-Year Clinical Outcomes and BPH Subgroup Analysis of Profound Medical’s Phase I Clinical Trial to be Included in Presentation at DGU 2018
18/09/2018
TORONTO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time [...]
Adverum to Present at Cantor Global Healthcare Conference
18/09/2018
MENLO PARK, Calif., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, today [...]
electroCore, Inc. to Present at the Cantor Global Healthcare Conference
18/09/2018
BASKING RIDGE, N.J., Sept. 18, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq:ECOR), a commercial-stage bioelectronic medicine company, today announced the company will be participating in the [...]
HealthEquity to Present at Investor Conference
18/09/2018
DRAPER, Utah, Sept. 18, 2018 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY), the nation’s largest independent health savings account (HSA) custodian, today announced that it plans to participate at the 2018 Cantor [...]
Idera Pharmaceuticals Announces Appointment of Howard Pien to its Board of Directors
18/09/2018
EXTON, Pa., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a pharmaceutical company focused on the development and commercialization of its proprietary immune modulator, tilsotolimod, for [...]
Principia Biopharma Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
18/09/2018
SOUTH SAN FRANCISCO, Calif., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Principia or the Company) (Nasdaq: PRNB), a clinical-stage biopharmaceutical company dedicated to bringing transformative oral [...]
Good Samaritan Canada acquires Delta View Campus of Care
18/09/2018
DELTA, B.C., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Good Samaritan Canada (GSC) and Devji Holdings Ltd. have reached an agreement that has transferred ownership of Delta View Campus of Care to Good Samaritan Canada [...]
Running Marathons and Co-Founding a Company: Accomplished Octogenarian Scientist Provides Inspiration for Senior Runners
18/09/2018
CHICAGO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Inspirotec Inc., a Chicago-based startup company with proprietary technology for measuring airborne allergens, today announced that its co-founder and Chief Scientific Officer [...]
Mount Sinai Joins Test Validation Trial of bioAffinity’s CyPath® Lung
18/09/2018
SAN ANTONIO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, today announced that the Icahn School of Medicine at Mount Sinai (ISMMS) in New York, NY, will be a clinical [...]

Pages